Accelerating the Development of a Malaria Vaccine

Research collaboration project, “Transmission-blocking Vaccine of Malaria”, has been accepted by the Global Health Innovative Technology Fund’s product development program. Hamamatsu Pharma Research to collaborate with the University of Florida's Emerging Pathogens Institute.

https://www.ghitfund.org/newsroom/press/detail/197/